Status:
COMPLETED
A Feasibility Trial and Protocol for Remote Cognitive Training Developed for Use in a Cognitively Healthy Adult Population During the COVID-19 Pandemic
Lead Sponsor:
University of Victoria
Conditions:
Cognition Disorders in Old Age
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The COVID-19 pandemic has created a shift in the use of at-home spaces for work, play and research. In the current study, the feasibility of implementing an at-home cognitive training tool called Neur...
Detailed Description
The work looks at the feasibility of using a newly developed anaglyph 3D cognitive training tool called NeuroTrackerX in research with adult participants. The work looks to validate an at-home program...
Eligibility Criteria
Inclusion
- Inclusion criteria for both groups included being aged 50 years and older and to have either normal or corrected vision.
Exclusion
- Exclusion criteria included the presence of any major neurocognitive disorder or the presence of visual deficits that impeded one's ability to complete the 3D task.
Key Trial Info
Start Date :
January 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05278273
Start Date
January 4 2021
End Date
March 10 2022
Last Update
March 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Victoria
Victoria, British Columbia, Canada, V8P5C2